Loading organizations...
§ Private Profile · Caesarea, Hefa, Israel
An organization with no publicly available details regarding its specific activities, products, or services based on current research.
Commonsense is a medical technology and femtech company developing smart panty-liners designed for continuous vaginal and urinary health monitoring, though its specific headquarters location remains publicly undisclosed. The organization operates within the broader women's health diagnostics sector, focusing on non-invasive wearable biosensors that track physiological biomarkers to detect potential gynecological or urological anomalies. At this time, the enterprise operates with an undisclosed employee count, and specific financial metrics regarding its total venture funding raised, post-money valuation, or active user count are not publicly available in standard market databases. Furthermore, the company has not formally announced strategic partnerships, institutional lead investors, or enterprise customers that would typically provide recognizable market validation within the digital health ecosystem. The exact founding year and the identities of the original founders behind the Commonsense smart diagnostic platform remain unverified in current corporate registries.
Commonsense has raised $20.0M across 1 funding round.
Commonsense has raised $20.0M in total across 1 funding round.
Commonsense has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series A in February 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 15, 2018 | $20M Series A | Playground Global | Aleph, Eric Schmidt | Announced |
Commonsense has raised $20.0M in total across 1 funding round.
Commonsense's investors include Playground Global, Aleph, Eric Schmidt.